Search Results - dawn+cochrane

2 Results

Sort By:

Anti-androgen therapy in triple-negative breast cancer

Methods of treating breast cancer with anti-androgen compounds. Reference patent 9,517,229 and application 15/373,914.

Published: 12/1/2023 | Inventor(s): Jennifer Richer Mouchantat, Dawn Cochrane, Andy Protter

Disease Areas Oncology

Category(s): Therapeutics

Micro RNAs that target metabolic enzymes and nutrient transporters in breast cancer

Patients with triple-negative breast cancer often have increased risk for recurrence and metastasis as well as decreased 5-year survival. Since triple-negative breast cancers don’t depend on hormone receptors or HER for growth, triple-negative cancers do not respond to hormone or HER dependent therapies. Jennifer Richer and her research team have...

Published: 11/30/2023 | Inventor(s): Jennifer Richer Mouchantat, Dawn Cochrane, Steven Anderson

Disease Areas Endocrine/Metabolism, Oncology

Category(s): Diagnostics